Report from Biovica’s Annual General Meeting on August 30, 2018

Below is a summary of the decisions taken at the Annual General Meeting, AGM. The Meeting resolved that available funds of SEK 60,768,811 will be carried forward. The Meeting resolved that Board members should be compensated with SEK 125,000 for Directors and SEK 200,000 for the Chairman of the Board. The Meeting also resolved that [...]

2021-04-11T00:10:31+02:00August 30th, 2018 18:36|Regulatory|

Biovica has completed supplement # 1 to the FDA with positive results

Biovica International AB (publ) today announced that the company received positive feedback from the FDA for the next step in the regulatory approval process. The feedback from the FDA ensures that the analytical validation is conducted in a manner that meets the FDA's requirements, so the product can get 510(k) clearance.

2021-04-11T00:10:31+02:00August 27th, 2018 08:00|Regulatory|